Sutro Biopharma, Inc.: Form 8-K, filed Sep 29, 2025
Filed with the SEC on Sep 29, 2025 and accepted by EDGAR at Sep 29, 2025, 17:15 ET.
Items reported
- Item 2.05 Exit or disposal costs
- Item 9.01 Financial statements and exhibits
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001193125-25-223434. Last ingested by Listed: Oct 24, 2026, 15:12 ET. Listed shows no prices and gives no investment advice.